| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FORVIS Fees | 5,725 | 5,725 |
| Category | Amount |
|---|---|
| NONE |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| SHS First Trust | 42,117 | 27,727 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 7,509 SHS Boston Scientific Corp | 169,703 | 434,095 |
| 299 SHS Corteva Inc | 0 | 14,328 |
| 299 SHS Dow Inc | 10,026 | 16,397 |
| 920 SHS Elanco Animal Health Inc | 13,166 | 13,708 |
| 112 SHS Intl Flavor & Fragrances | 10,354 | 9,068 |
| 2,341 SHS Eli Lilly & Co | 0 | 0 |
| 675 SHS Eli Lilly & Co | 0 | 0 |
| 1,156 SHS Eli Lilly & Co | 0 | 673,856 |
| 675 SHS Eli Lilly & Co | 612 | 393,471 |
| 1,081 SHS Eli Lilly & Co | 123,829 | 630,137 |
| 835 SHS Eli Lilly & Co | 493,059 | 486,738 |
| Description | Amount |
|---|---|
| Adjustment of Contribution to Cost Basis | 5,854 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Miscellaneous Expense | 150 | 150 |
| Description | Amount |
|---|---|
| Cost Basis Adjustment - Bonds | 5,504 |
| Cost Basis Adjustment - Grants Paid | 60,284 |
| Additional Other Increase | 3,407 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Bailey and Moore | 22 | 22 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Tax | 1,121 |